CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD) (Middle Region) Peptide
CEBPD
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN974821
Aperçu rapide pour CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD) (Middle Region) Peptide (ABIN974821)
Antigène
CEBPD
(CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CEBPD antibody (Catalog #: ARP38582_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CEBPD (CCAAT/enhancer Binding Protein (C/EBP), delta (CEBPD))
-
Sujet
-
CEBPD is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inf
Alias Symbols: C/EBP-delta, CELF, CRP3, NF-IL6-beta
Protein Interaction Partner: CEBPE,E2F1,LTF,RB1,CEBPA,CEBPB,CEBPE,CEBPG,CREBBP,EP300,RB1,RELA,SPI1,CEBPB,RELA,SMAD3,SMAD4
Protein Size: 269 -
Poids moléculaire
- 28 kDa
-
ID gène
- 1052
-
NCBI Accession
- NM_005195, NP_005186
-
UniProt
- P49716
Antigène
-
Vous êtes ici:
